Αποτελέσματα Αναζήτησης
Download PDF Guideline Development Process ... Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K. (2019) Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache ...
1 Δεκ 2020 · Migraine treatment is warranted in children if the headaches prevent the child from going through daily activities like going to school, playing, etc. Since migraine is prevalent in children and impacts the cause of their disability, effective treatment is likely to result in improved outcomes.
19 Σεπ 2022 · Headache (commonly defined as pain located above the orbitomeatal line) is one of the most common complaints in children and adolescents. It is recognized as one of the top medical and neurologic contributors to the global burden of disease and is a leading cause of disability in adolescents and young adults (age 10 to 24 years) [1,2].
migraine treatments in children and adolescents. The guide-line seeks to answer the following clinical question: In children and adolescents with migraine, do acute self-administered treatments, compared with placebo, reduce headache pain and associated symptoms (nausea, vomiting, photophobia, and phonophobia) and maintain headache freedom?
Headache is very common in children and young people. The correct advice and treatment requires consideration of a wide differential diagnosis between primary and secondary headaches, and also of the different types of primary headache. The International Classification of Headache Disorders gives useful descriptions and diagnostic criteria that ...
17 Σεπ 2019 · Recommendations for the treatment of acute migraine in children and adolescents focus on the importance of early treatment, choosing the route of administration best suited to the characteristics of the individual migraine attack, and providing counselling on lifestyle factors that can exacerbate migraine, including trigger avoidance and ...
Sumatriptan 10 mg and zolmitriptan 5 mg as nasal spray are approved for the treatment of migraine in adolescents age 12 or older. In triptan studies, the high placebo response and the short duration of attacks were methodical problems in showing efficacy of triptans in children under the age of 12 years.
